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ABSTRACT Two major isoforms of aquaporin-4 (AQP4) have been described in human tissue. 
Here we report the identification and functional analysis of an alternatively spliced transcript 
of human AQP4, AQP4-Δ4, that lacks exon 4. In transfected cells AQP4-Δ4 is mainly retained 
in the endoplasmic reticulum and shows no water transport properties. When AQP4-Δ4 is 
transfected into cells stably expressing functional AQP4, the surface expression of the full-
length protein is reduced. Furthermore, the water transport activity of the cotransfectants is 
diminished in comparison to transfectants expressing only AQP4. The observed down-regu-
lation of both the expression and water channel activity of AQP4 is likely to originate from a 
dominant-negative effect caused by heterodimerization between AQP4 and AQP4-Δ4, which 
was detected in coimmunoprecipitation studies. In skeletal muscles, AQP4-Δ4 mRNA expres-
sion inversely correlates with the level of AQP4 protein and is physiologically associated with 
different types of skeletal muscles. The expression of AQP4-Δ4 may represent a new regula-
tory mechanism through which the cell-surface expression and therefore the activity of AQP4 
can be physiologically modulated.
INTRODUCTION
Aquaporin-4 (AQP4) is a water-selective membrane protein ex-
pressed in the CNS and other tissue, including skeletal muscle (Frigeri 
et al., 1995, 1998). The two major isoforms produced by the aqua-
porin gene are M1 and M23 (Jung et al., 1994), which are arranged 
in the plasma membrane to form supramolecular structures called 
orthogonal arrays of particles (OAPs). Of importance, the size and 
number of OAPs depend on the ratio between the two major iso-
forms, the longest being M1, the OAP size-limiting isoform (Nicchia 
et al., 2010). Although the physiological role of OAPs is not known, 
they were recently identified as the major target of AQP4 autoanti-
bodies produced by patients affected by neuromyelitis optica, a de-
myelinating autoimmune disease (Nicchia et al., 2009). Studies dis-
covered the expression of other AQP4 isoforms in rat tissue (Moe 
et al., 2008), and in particular the Mz isoform of AQP4 appears to 
affect OAP formation. However, the Mz isoform is not expressed in 
humans (Rossi et al., 2012) and thus is of limited interest.
The regulation of AQP4 expression and/or activity is one of the 
major issues in studies regarding the physiopathological role of 
AQP4. There are contrasting data regarding AQP4 short-term regu-
lation by phosphorylation. Previous reports on transfected cells sug-
gested inhibition of activity by Ser-180 phosphorylation (Han et al., 
1998; Zelenina et al., 2002; McCoy et al., 2010), and other studies 
showed activation after phosphorylation of Ser-111 (Gunnarson 
et al., 2008). However, in rat astrocyte primary cultures, which retain 
a high level of AQP4 protein, phosphorylation appears not involved 
in modulating its activity (Nicchia et al., 2008), and Ser-111 appears 
not involved in AQP4 channel gating (Assentoft et al., 2013).
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C-terminal motif of AQP4-Δ4 is still intracellular (Supplemental 
Figure S1), and therefore the general topological structure of the 
N- and C-termini is retained.
PCR and quantitative PCR specific for AQP4 alternative 
splicing isoforms and protein expression in human tissues
To establish whether AQP4-Δ4 expression is restricted solely to the 
human deltoid, Real time-PCR (RT-PCR) was used to determine its 
expression in other skeletal muscles (thenar eminence, masseter), 
as well as in the cerebrum and cerebellum. Primers used for PCR 
(P3 and P4 in Figure 2A) were complementary to the exon 3 and 
5 regions and amplified both AQP4 and AQP4-Δ4 fragments, gener-
ating two amplicons of 299 and 218 base pairs, respectively. As posi-
tive control we performed PCR on total RNA extracted from HeLa 
cells transfected with M1 or M1-Δ4 in molar ratio 1:1.
Coamplification of AQP4-spliced variant with full-length AQP4 
from five different human cDNAs showed that the full-length was 
the most abundant AQP4 mRNA (Figure 2B). AQP4-Δ4 was de-
tected in all skeletal muscles analyzed. A high level of AQP4-Δ4 ex-
pression was observed in the thenar eminence muscles of the hu-
man hand palm and masseter, whereas moderate expression was 
detected in the deltoid, in which, according to the analysis on the 
CDS library, the AQP4-Δ4 transcript represented 15% of total AQP4 
transcripts.
To accurately quantify full-length and AQP4-Δ4 mRNA in dif-
ferent tissues, we used quantitative PCR (qPCR). Figure 2E shows 
the absolute copy number of each isoform. Both cerebellum and 
brain expressed high levels of full-length AQP4 mRNA compared 
with the skeletal muscle sample. Furthermore, analysis of the 
abundance of AQP4-Δ4 mRNA revealed that the relative amounts 
of AQP4-Δ4 in the thenar eminence were threefold and eightfold 
greater than those found in brain and cerebellum, respectively 
(Figure 2E, right). Of interest, despite the thenar eminence and 
deltoid having the same copy number as full-length AQP4, the 
percentage of deleted isoform with respect to the total was about 
twice as great in thenar eminence than in the deltoid. Of interest, 
AQP4-Δ4 mRNA was also amplified from brain and cerebellum to 
the same amount as for skeletal muscle samples, but its relative 
expression compared with the full length corresponded to only 
∼5–10%.
The AQP4 protein expression levels were examined by immuno-
blotting (Figure 2D). M1-AQP4-Δ4 has a predicted molecular weight 
of 30 kDa, and hence it is indistinguishable from M23-AQP4. In the 
human skeletal muscle biopsies analyzed, only the deltoid showed 
moderate expression of AQP4 isoforms, whereas the thenar emi-
nence and masseter only displayed a weak signal. Of interest, by 
comparing the immunoblotting with the PCR results (Figure 2, B and 
D), it can be deduced that the higher the percentage of AQP4-Δ4 
isoform, the lower is the protein expression in the tissue. This was 
particularly evident in the deltoid and thenar eminence muscles, 
showing equal full-length copy number but different AQP4-Δ4 
amounts, which appeared to be inversely proportional to the pro-
tein levels of AQP4.
Characterization of AQP4-Δ4 protein: a dominant-negative 
effect on AQP4 expression
Initial data reported in Figure 2 suggest that the spliced isoform 
may have a dominant-negative effect on AQP4 expression levels. 
Thus, to investigate the role played by AQP4-Δ4 on AQP4 total 
protein expression levels, we transiently cotransfected equal 
amounts of AQP4 and AQP4-Δ4 or “empty vector” plasmids into 
HeLa cells and analyzed the AQP4 protein level by Western blot. 
A second way in which AQP4 may be regulated is linked to its 
translocation to the plasma membrane. Several studies performed 
using cultured astrocytes report a significant intracellular AQP4 
expression, which would suggest the need for AQP4 trafficking 
(Nicchia et al., 2008; Potokar et al., 2013). However, in the brain 
AQP4 is largely expressed in the glial cell plasma membrane, with 
no significant intracellular pool, suggesting that there is no need for 
regulation of water transport by AQP4 translocation in the CNS.
The third way in which AQP4 is regulated is by changes in ex-
pression levels. Several studies report changes in the surface ex-
pression of AQP4, mainly in pathological conditions. Loss of AQP4 
has been reported in ischemia (Frydenlund et al., 2006), brain injury, 
and models of Duchenne muscular dystrophy (Frigeri et al., 2001) 
and Alzheimer’s disease (Yang et al., 2011). However, the molecular 
signaling that induces these changes is not known, nor is whether 
analogous changes happen under physiological conditions.
Finally, recent studies indicate a complex mechanism of transla-
tional control of AQP4 that could be responsible for the different 
expression of the two major isoforms in AQP4-expressing tissues 
(Rossi et al., 2010; Pisani et al., 2011). These reports also suggest 
that regulation of AQP4 expression and OAP formation and size can 
occur at the posttranscriptional level. Furthermore, it is likely that 
additional posttranscriptional mechanisms occur to finely regulate 
AQP4 expression or function. Indeed, it is not known why tissues 
expressing similar levels of AQP4 mRNA display large differences in 
AQP4 protein content.
To evaluate the expression of new AQP4 isoforms in tissues in 
which the quantitative levels of AQP4 protein are low compared 
with the levels of AQP4 mRNA (i.e., skeletal muscle), we generated 
and screened a human skeletal muscle coding sequence (CDS) li-
brary of AQP4 transcripts. We identified a novel short isoform of 
human AQP4 and named it AQP4-Δ4, as it is generated from alter-
native splicing of exon 4 of the aquaporin-4 gene, leading to an in-
frame deletion of exon 4 in the AQP4 mRNA. We found that this 
isoform is expressed in skeletal muscle and has a negative-dominant 
effect on the full-length protein, suggesting a new way to modulate 
membrane expression and activity of water transport in AQP4-ex-
pressing tissues.
RESULTS
AQP4 CDS library reveals a new mRNA splicing isoform 
in human skeletal muscle
The human AQP4 gene occupies the q11.2 position on chromo-
some 18 and consists of five exons that span 13.75-kb pairs. We 
constructed AQP4-CDS libraries from two human tissues: skeletal 
muscle and cerebellum. CDS library analysis in human deltoid 
showed the lack of 81 base pairs corresponding to the entire exon 4 
of AQP4 in ∼15% of isolated clones (Figure 1). These clones, contain-
ing the M1 starting methionine, were in-frame and therefore could 
potentially express a new isoform, which we named AQP4-Δ4 
(GenBank: KF055862). No AQP4-Δ4 isoform was isolated from hu-
man cerebellum. In total, 35 clones were analyzed for both libraries.
If translated from M1, this new isoform could produce a 
smaller AQP4 protein of 296 amino acids missing the final part of 
transmembrane helix 5 and loop E (Figure 1B). Protein hydro-
phobicity plots of the AQP4-Δ4 transcript demonstrated that 
loss of exon 4 would leave the general transmembrane helix 
structure intact and with no frame shift, but the second, highly 
conserved NPA motif is absent. This motif contains a structural 
domain that plays a crucial role in AQP4 membrane targeting 
and water-selective permeation (Guan et al., 2010). Immunofluo-
rescence experiments, using transfected cells, indicate that the 
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The level of the different AQP4 variants was determined by 
Western blot analysis over an 8-h interval. AQP4 (half-life, >8 h) 
appeared to be significantly more stable than AQP4-Δ4, the 
expression of which rapidly decreased after 2 h of incubation with 
CHX, thus exhibiting a rapid turnover (Figure 4A).
To further investigate AQP4-Δ4 turnover, we treated HeLa cells 
with the well-characterized proteasome inhibitor MG132 for 7 h 
and probed immunoblots of total cell lysate with anti-AQP4 anti-
bodies (Figure 4B). AQP4-Δ4 increases its expression level three-
fold after proteasome inhibition, suggesting that its rapid turnover 
is due to proteasome degradation (Figure 4C).
To study AQP4 stability in the presence of AQP4-Δ4, we de-
signed pulse-chase experiments on transiently transfected cells 
(Figure 4D). These experiments were performed using in vivo la-
beling of cells with a [35S]methionine-cysteine mixture (see 
Materials and Methods), followed by chase for an indicated time 
(0–4 h) and subsequent immunoprecipitation.
The most relevant observation was the inhibition of AQP4 expres-
sion in the presence of AQP4-Δ4, supporting a dominant-negative 
modulation of the AQP4-Δ4 variant (Figure 3, A–C). The negative 
effect of AQP4-Δ4 was confirmed by immunofluorescence on 
cotransfected cells, in which the expression of the splice variant 
down-regulated AQP4 expression (Figure 3G). Of importance, this 
dominant-negative modulation also occurs in rat astrocyte primary 
cell cultures, which express high levels of endogenous AQP4 
(Nicchia et al., 2008). Indeed, transfection of astrocytes with 
AQP4-Δ4 leads to a decrease in AQP4 protein levels compared with 
the same cells transfected with an empty plasmid (Figure 3, D–F).
Characterization of AQP4-Δ4: protein stability and 
dominant-negative effect
To estimate the half-life of the two AQP4 variants, transfected HeLa 
cells with AQP4 and AQP4-Δ4 were treated with cycloheximide 
(CHX) to inhibit protein synthesis.
FIGURE 1: Characteristics of the alternatively spliced transcript of human AQP4. (A) Schematic representation of the 
human AQP4 gene (top), the normally spliced AQP4 isoform (middle), and the exon-skipped AQP4-Δ4 isoform (bottom). 
The exons are shown as boxes, and their relative sizes are depicted; alternative splicing patterns are indicated as lines 
connecting the exons. (B) Nucleotide and amino acid (capital letters) sequences of AQP4. The alternatively spliced exon 
4 and the related 27 deleted amino acids are shown in red. (C) Transmembrane topology of AQP4 showing relative 
orientation of N- and C-termini, transmembrane segments (numbers), and loops (capital letters). The deleted portion is 
indicated in green. (D, E) Location of deleted portion (green) in AQP4 monomer (D) and AQP4 tetramer (E) in structural 
models designed using PyMOL software (De Lano Scientific). (F, G) Topological prediction of AQP4-Δ4 with predicted 
transmembrane regions and probability graphs by TMHMM (www.cbs.dtu.dk/services/TMHMM/) and (G) OCTOPUS 
(http://octopus.cbr.su.se/).
Volume 25 February 15, 2014 Human AQP4-spliced isoform | 473 
whereas it did colocalize extensively with the ER marker (Figure 5, top 
and middle). This improper trafficking also occurred in rat astrocyte 
primary cell cultures (Figure 5, bottom). Weak staining of AQP4-Δ4 
was also observed at the plasma membrane level (Supplemental 
Figures S2 and S3). These data indicate that the AQP4-Δ4 splice vari-
ant mostly resides in the ER. The improper trafficking and ultimate 
degradation of AQP4-Δ4 is consistent with its rapid turnover.
AQP4-Δ4 dominant-negative effect by protein misrouting 
and hetero-oligomeric complexes
There are several examples of truncated splice variants with altered 
trafficking that are able to misroute their respective canonical protein 
(Karpa et al., 2000; Sarmiento et al., 2004; Zmijewski and Slominski, 
2009). Thus we tested the hypothesis that the function of AQP4-Δ4 
protein is to control cell surface expression of the full-length protein 
by accumulating the newly synthesized channels in the ER.
To this purpose, we cotransfected HeLa cells with AQP4 tagged 
with GFP and calreticulin-RFP in the presence or absence of 
AQP4-Δ4. After 30 h of transfection, we examined cells by confocal 
microscopy. Image analysis (Figure 6A) showed retention of 
full-length AQP4 in the ER in the presence of AQP4-Δ4 compared 
with cells only expressing AQP4. Finally, to analyze whether the 
degradation of AQP4 requires physical interaction with AQP4-Δ4, 
we performed coimmunoprecipitation experiments. In these experi-
ments (Figure 6B), AQP4-Δ4 was tagged with GFP and immunopre-
cipitated with anti-GFP antibodies, and immunoblots were per-
formed with anti-AQP4 antibodies. Transfected cells were treated 
for 7 h with 15 μM proteasome inhibitor MG132 to prolong AQP4-Δ4 
In the absence of AQP4-Δ4 the AQP4 protein decreased slightly 
(in the range of 70%) during a 4-h chase (Figure 4E, open circles). In 
contrast, in the presence of AQP4-Δ4, the AQP4 signal decreased 
rapidly and significantly during the chase (down to 40% after 4 h; 
Figure 4E, filled square).
To evaluate whether the proteasome pathway is responsible 
for AQP4 down-regulation in the presence of AQP4-Δ4, we con-
ducted pulse-chase experiments in the presence of the protea-
some inhibitor MG132.
In MG132-treated cells, the degradation of AQP4 in the pres-
ence of AQP4-Δ4 significantly slowed and was comparable to AQP4 
degradation in the absence of AQP4-Δ4, suggesting that the domi-
nant-negative effect of AQP4-Δ4 on AQP4 occurs via the protea-
some pathway.
Characterization of AQP4-Δ4: protein subcellular 
localization
Because the biological function of AQP4 is intimately linked to its 
membrane localization, we determined the subcellular localization of 
the novel isoform. Green fluorescent protein (GFP)–tagged AQP4-Δ4 
expressed in transfected cells presented a major intracellular localiza-
tion, suggesting reduced labeling at the plasma membrane (Figure 
5). To analyze the subcellular compartment in which the AQP4-Δ4 
variant is retained, we cotransfected cells with AQP4-Δ4-GFP and 
calreticulin–red fluorescent protein (RFP), a chaperone protein located 
in the endoplasmic reticulum (ER), or with the trans-Golgi glycosyl-
transferase-RFP. We examined cellular localization by confocal mi-
croscopy. The AQP4-Δ4 signal did not overlap with the Golgi marker, 
FIGURE 2: Expression of AQP4 transcripts and protein in human tissue. (A) Primers used for RT-PCR and qPCR with 
their relative location in AQP4 and AQP4-Δ4 mRNA. (B) Coamplification by RT-PCR of AQP4 splice variant with 
full-length AQP4 from four different human cDNAs. Two bands are visible in skeletal muscles. No AQP4-Δ4 amplicon 
was detected in human cerebellum. (C) Histogram showing percentage of AQP4-Δ4 (Δ4) relative to the total measured 
by RT-PCR (*p = 0.03, n = 3). (D) Immunoblot detection of AQP4 protein expressed in human brain and skeletal muscle. 
Two bands of 32 and 30 kDa were detected corresponding, respectively, to M1 and M23. Actin was used as a loading 
control. (E) qPCR analysis showing absolute quantities of AQP4 and AQP4-Δ4 mRNA (left) and the ratio between the 
two forms (right) in human tissue using isoform-specific primers (*p < 0.05, n = 4; **p < 0.01, n = 4).
474 | M. De Bellis et al. Molecular Biology of the Cell
rat skeletal muscles with different fiber com-
position and glycolytic capacity, we evaluated 
two typical fast-twitch muscles, namely the 
extensor digitorum longus (EDL) and quadri-
ceps, and a typical slow muscle, the soleus 
(Figure 8). Furthermore, we also analyzed the 
flexor digitorum brevis (FDB), which is an oxi-
dative glycolytic fast-twitch muscle with pe-
culiarly low AQP4 expression. Coamplifica-
tion of AQP4 splice variant with full-length 
AQP4 showed that the full-length form was 
the most abundant AQP4 mRNA in skeletal 
muscle (Figure 8A). Although at a low level, 
AQP4-Δ4 was detected in rat skeletal mus-
cles, and its relative amount was about four 
times higher in the FDB and soleus com-
pared with the EDL and quadriceps (Figure 
8B). These data were inversely related to the 
protein levels of AQP4 in the same muscles 
(Figure 8C) and in agreement with findings in 
human skeletal muscles (Figure 2). Thus the 
low AQP4 protein expression levels in the 
soleus and FDB are likely to be the result of 
the negative effect of higher expression lev-
els of AQP4-Δ4 mRNA. This suggests that 
AQP4-Δ4 actively regulates the functional 
expression of AQP4 in skeletal muscle.
DISCUSSION
We recently demonstrated the existence of a 
complex mechanism of AQP4 translational 
control via leaky scanning and reinitiation 
(Rossi et al., 2010; Pisani et al., 2011), which 
allows the synthesis of the AQP4-M23 iso-
form from M1 mRNA. However, this mecha-
nism could be part of a more complex net-
work, which could account for discrepancies 
between the protein and mRNA AQP4 levels 
in different tissues and different physiopatho-
logical conditions described in the literature.
In the present study we identified a novel 
alternative spliced isoform of AQP4 derived 
from exon 4 skipping, which could be implicated in the mechanism 
of tissue-specific posttranscriptional regulation of AQP4 production 
through alternative splicing and a dominant-negative effect. Alterna-
tive splicing of pre-mRNA plays a key role in posttranscriptional gene 
regulation by generating distinct protein variants from the same ge-
netic information, which differ in structure and function compared 
with the full-length protein. It has been estimated that >90% of all 
human multiexon genes are alternatively spliced (Wang et al., 2008). 
The importance of alternative splicing has been well established in 
normal development and differentiation (Kalsotra and Cooper, 
2011). Furthermore, alternative splicing regulates quantitative levels 
of proteins in two ways: by producing alternative transcripts carrying 
a premature termination codon, resulting in nonsense-mediated 
mRNA degradation, and, if the aberrant transcript is translated, 
down-regulation of the corresponding protein levels via dominant-
negative mechanisms (Kim et al., 2008; Shyu et al., 2008).
An initial sequence analysis of AQP4 intronic splicing acceptors 
shows that the splicing acceptors of introns 3 and 4 (flanking exon 
4) are very similar and that the polypyrimidine tract of introns 1–3 
contains UUCU elements, which are the binding sites for the 
half-life. The results showed copurification of AQP4 with AQP4-Δ4, 
demonstrating physical interaction between the two isoforms.
Effect of AQP4-Δ4 on plasma membrane water permeability
To test whether the expression of AQP4-Δ4 resulted in a reduction 
in AQP4-mediated water transport, we transiently transfected a sta-
bly expressing AQP4 cell line with AQP4-Δ4 (Figure 7). Water trans-
port measurement showed strongly reduced osmotic cell response 
in the presence of AQP4-Δ4, in line with the hypothesis of its domi-
nant-negative effect. Furthermore, a stable cell line expressing high 
levels of AQP4-Δ4 showed no increase in water permeability com-
pared with wild-type cells. These data indicate that AQP4-Δ4 is not 
a functional water channel, and its dominant-negative effect causes 
a reduction in plasma membrane water permeability due to reduc-
tion in AQP4 plasma membrane abundance.
AQP4-Δ4 mRNA in rat skeletal muscle inversely correlates 
with AQP4 protein expression
AQP4 expression is associated with the glycolytic capacity of the mus-
cle (Basco et al., 2013). To analyze the expression level of AQP4-Δ4 in 
FIGURE 3: Dominant-negative effect of AQP4-Δ4 in mammalian cells. (A, B) Immunoblot 
analysis of AQP4 expression in HeLa cells cotransfected with AQP4 and AQP4-Δ4 (Δ4), both 
cloned into pTARGET or empty vector (EV). Protein samples were analyzed by SDS–PAGE (A) or 
blue native PAGE (BN-PAGE; B). (C) Densitometric analysis reported as AQP4/actin expression 
ratio. The histogram shows the analysis of five independent experiments (*p < 0.05). 
(D, E) AQP4 expression in rat primary astrocyte cultures transfected with deleted isoform, 
cloned into pTARGET mammalian expression vector or empty vector, and analyzed by 
SDS–PAGE (D) or BN-PAGE (E). The multiple bands detected after BN-PAGE (B, D) correspond 
to supramolecular organization (i.e., OAPs) of AQP4. (F) Histogram for the densitometric 
analysis of the protein bands in D, calculated as AQP4/GFAP expression ratio. Analysis of three 
independent experiments (*p < 0.05). (G) Immunofluorescence AQP4 staining in HeLa cells 
cotransfected with AQP4 and empty vector (EV) or AQP4 and AQP4-Δ4 in a 1:1 ratio. Scale bar, 
50 μm. Images are representative of six independent experiments.
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experiments reveal that AQP4-Δ4 accumulates in the ER as opposed 
to full length AQP4, which is expressed mostly in the plasma mem-
brane. As a consequence, retention of AQP4-Δ4 in the ER targets 
this protein for degradation, as demonstrated with proteasome inhi-
bition experiments. The improper trafficking and ultimate degrada-
tion of AQP4-Δ4 are consistent with its rapid turnover as demon-
strated by protein synthesis inhibition with cycloheximide.
Using qPCR analysis, we found that the AQP4-Δ4 transcript has 
similar mRNA levels in CNS and skeletal muscle, but its relative 
amount is much higher in skeletal muscle samples. This implies that 
the expression of AQP4-Δ4 mRNA is not limited to human skeletal 
muscle and suggests that it may be subjected to regulation under 
physiological or pathological conditions. Of importance, the expres-
sion levels of AQP4-Δ4 mRNA in different human muscles inversely 
correlated with total AQP4 protein expression level. Moreover, we 
showed by ectopic expression of AQP4 forms in mammalian cells 
and rat astrocyte primary cultures that AQP4-Δ4 exerts a dominant-
negative effect over the full-length AQP4 protein. This makes a 
substantial functional difference from reports on other intracellular 
polypyrimidine tract–binding protein (PTB). Of interest, PTB dif-
ferentially modulates alternative splicing of a set of muscle-specific 
transcripts, allowing expression of muscle-specific isoforms (Lin 
and Tarn, 2011). Therefore it is possible to hypothesize that, during 
AQP4 pre-mRNA splicing, exon 4 skipping may occur via PTB.
Structure–function relationship of AQP4-Δ4
AQP4 exon 4 (81 base pairs) encodes 27 amino acids, and its skip-
ping removes the final part of transmembrane helix 5 and loop E of 
the full-length AQP4. Of importance, the second NPA motif, which is 
coded by exon 4, is lost in AQP4-Δ4. Demonstrating its essential role 
in the formation of the structural domain for water permeation in the 
aquaporin monomeric channel (Guan et al., 2010), water permeabil-
ity experiments indicate loss of function of AQP4-Δ4. Furthermore, 
the spliced protein overexpressed in a stable cell line does not in-
crease basal cell water permeability, thus further demonstrating loss 
of function of AQP4-Δ4. Although there is a report of one splice vari-
ant of AQP4 in rat that lacks exon 2 (Moe et al., 2008), AQP4-Δ4 is 
the first human AQP4 splice product reported. Confocal microscopy 
FIGURE 4: AQP4-Δ4 protein stability and dominant-negative effect. (A) Immunoblot analysis of AQP4 expression in 
HeLa cells transfected with AQP4 or AQP4-Δ4 and treated with 30 μM CHX for the indicated duration to stop protein 
synthesis. (B) Immunoblot analysis of AQP4-Δ4 (Δ4) levels in transiently transfected HeLa cells treated or not with 15 μM 
MG132 proteasome inhibitor (MG132 ±). (C) Histograms for the densitometric analysis of the AQP4 expression levels 
obtained after CHX treatment (left; mean ± SE; **p < 0.01; n = 3–5 independent experiments) or MG132 treatment 
(right; n = 3 or 4 independent experiments; *p < 0.05). (D) HeLa cells transiently transfected with AQP4 alone or in the 
presence of dominant-negative AQP4-Δ4 were labeled for 30 min with [35S]cysteine/methionine and chased for the 
indicated times. Cells were then solubilized, and lysates were immunoprecipitated with anti-AQP4 antibody and analyzed 
by autoradiography as described in Materials and Methods. Where indicated, transfected HeLa cells were pretreated 
with 30 μM proteasome inhibitor MG132 for 3 h before starvation, and proteasome inhibitor was maintained throughout 
the experiments. (D) Representative autoradiograms of immunoprecipitated proteins with chase times of 0, 1, 2, and 4 h. 
(E) Averaged kinetics of protein degradation from four independent sets of experiments (mean ± SE; **p < 0.01).
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in transfected cells (Gunnarson et al., 2008), 
has not been confirmed in other models 
(Nicchia et al., 2008; Assentoft et al., 2013). 
However, the incongruence between mRNA 
and protein levels suggests a posttranscrip-
tional level of regulation. We postulate that 
the functional significance of AQP4-Δ4 may 
reside in its ability to modulate AQP4 ex-
pression and activity at the posttranslational 
processing level. Of interest, from the con-
focal microscopy analysis (see also Supple-
mental Figure S3) it emerges that a minor 
amount of AQP4-Δ4 is still able to reach the 
plasma membrane, but this quantity would 
not increase the water transport. This sug-
gests that AQP4-Δ4 can have a dual role of 
controlling plasma membrane water perme-
ability by a dominant-negative effect and by 
insertion of inactive channels. This mecha-
nism may be particularly relevant in skeletal 
muscle, where AQP4 is expressed in fast-
twitch fibers, and particularly in those char-
acterized by high glycolytic activity. Analysis 
of AQP4 in human skeletal muscles revealed 
that the level of AQP4-Δ4 mRNA inversely 
correlated with the total AQP4 protein ex-
pression levels. Of importance, the same 
correlation was assessed in rat skeletal mus-
cle and in particular between slow muscle, 
such as the soleus, and fast muscle, such as 
the EDL. This indicates that in skeletal mus-
cle AQP4-Δ4 substantially contributes to 
regulating the protein expression level of 
AQP4 and is responsible for the differences 
observed between fast and slow muscle. 
Thus the observed dominant-negative ef-
fect is a physiological mechanism that regulates AQP4 expression in 
slow and fast skeletal muscles. Further studies are required to deter-
mine the extent of this regulation in other tissues where AQP4 is 
strongly expressed and in tissues such as cardiac muscle, where 
AQP4 mRNA has been detected with minimal or no protein expres-
sion. Finally, aberrant AQP4-Δ4 expression could potentially lead to 
abnormal regulation of water balance, which may be involved in 
neurological and muscular disorders. For example, in dystrophic 
muscle of the mdx mouse—the animal model of Duchenne muscu-
lar dystrophy—the expression level of AQP4 protein is strongly re-
duced, but the level of mRNA is unaltered.
In conclusion, we identified and characterized an alternatively 
spliced form of AQP4 expressed in human skeletal muscle that 
modulates the protein level of full-length AQP4 in a dominant-neg-
ative way. Expression of AQP4-Δ4 may be an efficient mechanism 
for posttranscriptional regulation of AQP4 production and regula-
tion of the water permeability of the plasma membrane.
MATERIALS AND METHODS
Human samples
Total human cerebellum, kidney, and stomach RNA was obtained 
from Clontech (Diatech Lab Line Srl, Milan, Italy), and total human 
brain frontal cortex RNA was obtained from Agilent Technologies 
(Milan, Italy). Human skeletal muscle samples were obtained from 
patients who underwent surgery. In detail, skeletal muscle biopsies 
were obtained from surgical removal of deep soft tissue that, after 
aquaporins such as AQP2, AQP6, and AQP11 (Nozaki et al., 2008). 
Indeed, AQP2 is localized in vesicles that recycle to the apical mem-
brane of kidney collecting duct principal cells under vasopressin stim-
ulation. Furthermore AQP6 and AQP12 have been reported to be 
exclusively intracellular: AQP6 in endosomes of kidney intercalated 
cells of the collecting duct (Yasui et al., 1999), and AQP11 was found 
to have an essential role in ER homeostasis in kidney and liver (Rojek 
et al., 2013).
Expression of AQP4-Δ4 as a new way to attenuate AQP4 
expression and reduce water permeability of the plasma 
membrane
The dominant-negative effect that AQP4-Δ4 exerts over the full-
length form could be explained by the oligomeric structure of AQP4 
tetramers. It can be hypothesized that multimeric complexes formed 
by the full-length and truncated isoforms are probably retained in 
the ER because they are incorrectly assembled and, thus, targeted 
for degradation. This indicates that exon 4 is required for departure 
of AQP4 from the ER and for its forward transport through the 
plasma membrane pathway. Together these results suggest that in-
hibition of AQP4 by the AQP4-Δ4 variant is due to a protein–protein 
interaction in the ER, which, in turn, leads to a reduction in mature 
AQP4 expression in the plasma membrane.
The regulation of AQP4 expression/activity has not been thor-
oughly demonstrated. For example, short-term regulation by 
phosphorylation, which has been proposed to regulate AQP4 activity 
FIGURE 5: AQP4-Δ4 protein subcellular localization. Confocal image of localization of AQP4-Δ4 
(Δ4, green) in transfected HeLa cells and rat astrocyte primary cultures using subcellular markers 
(red). Note the colocalization of the spliced isoform with ER in both cell types. Images are 
representative of six independent experiments. Scale bar, 15 μm.
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Australia) and clustalW European Bioinformatics Institute Tools 
(www.ebi.ac.uk/Tools/clustalw2/index.html).
RNA extraction, RT-PCR, and quantitative RT-PCR
Human and rat RNA extraction was carried out using TRIzol accord-
ing to the instruction manual. Two micrograms of total RNA from 
human and rat tissues was reverse transcribed using ThermoScript 
reverse transcriptase (Invitrogen). PCR primers (P3 and P4 for human 
and P9 and p10 for rat; Table 1) were designed so that the coampli-
fied PCR products derived from either AQP4 or AQP4-Δ4 splice 
variant could be readily distinguishable on 2% agarose gel.
AQP4 and the spliced variant AQP4-Δ4 were analyzed by 
real-time quantitative RT-PCR using Power Syber Green and the 
StepOne Real-Time PCR Detection System (Applied Biosystems, 
Milan, Italy). Primers were designed using PrimerExpress software 
(Applied Biosystems). The primers used were P5 and P6 (Table 1) for 
both isoforms Ex 1/2 amplification and P7 and P8 (Table 1) for spe-
cific AQP4-Δ4 Ex 3/5 amplification. The standard curve approach 
was used to obtain absolute quantification of the AQP4 mRNA 
(AQP4 and AQP4-Δ4) copy numbers in real-time PCR. The standard 
curve for AQP4 mRNA quantification was obtained using the pTar-
get vector (circular or linear) containing human AQP4 or AQP4-Δ4 
CDS. The standard template log(copy number) was calculated as 
reported in previously (Wong and Medrano, 2005), and the target 
copy number was calculated using the same standard curve. Within 
each experiment, PCRs were performed in duplicate. Each PCR was 
evaluated by melting-curve analysis.
histology analysis, proved to be benign lesions of the soft tissues. 
Informed consent was obtained from patients. From each sample, 
depending on the size of the tissue, two portions were obtained for 
RNA and protein extraction.
Human AQP4 CDS library and sequencing
Human deltoid RNA extraction was carried out using TRIzol reagent 
(Invitrogen, Milan, Italy) according to the instruction manual. One 
microgram of total cerebellum and deltoid RNA was retrotrans-
cribed using Super Script III reverse transcriptase (Invitrogen) as 
recommended by the manufacturer, and the single-stranded cDNA 
obtained was PCR amplified using primers P1 and P2 described in 
Table 1. PCR products were analyzed using 1% agarose gel by elec-
trophoresis in TAE (Tris-acetate-EDTA) buffer. The selected PCR 
fragment of the expected size (1 kb) was cut from the agarose gel 
after electrophoresis separation, purified using the Qiaex II gel ex-
traction kit (Qiagen, Milan, Italy), and then cloned into pCR2.1-
TOPO vector using the Topo TA Cloning kit (Invitrogen). The re-
combinant vector was then transformed into chemically competent 
Escherichia coli. The recombinant E. coli harboring the recombinant 
plasmid was screened in selective Lysogeny broth (LB)/isopropyl-β-
d-thiogalactoside/X-gal/ampicillin/agar plates (AmpBlue; Invitro-
gen). White colonies were cultured overnight in LB medium contain-
ing 50 μg/ml ampicillin, and plasmid DNA was isolated using 
QIAprep Spin Miniprep Kit (Qiagen) and sequenced (BMR 
Genomics, Padua, Italy). Analysis and multialignment of sequences 
were performed using ChromasLite2 (Technelysium, South Brisbane, 
FIGURE 6: AQP4 WT is retained in ER when coexpressed with AQP4-Δ4. (A) Confocal images of full-length AQP4 and 
AQP4-Δ4 (green) with ER marker (red). Note that full-length AQP4 in the presence of the spliced isoform (Δ4) is strongly 
retained in the ER compartment (bottom). Images are representative of four independent experiments. Scale bar, 
15 μm. (B) Immunoblot of anti-GFP precipitated proteins revealed with anti-AQP4 antibodies. HeLa cells were 
cotransfected with the indicated expression constructs and treated for 7 h with 15 μM proteasome inhibitor MG132 to 
prolong AQP4-Δ4 half-life; immunoprecipitation with agarose beads was performed using anti-GFP (anti-GFP) or rabbit 
(immunoglobulin G) antibodies. The top band corresponds to AQP4-GFP, and the bottom band corresponds to AQP4 
without a tag. Note the presence of AQP4 in the second lane. EV, empty vector.
478 | M. De Bellis et al. Molecular Biology of the Cell
For proteasome inhibition experiments, 24 h posttransfection, 
HeLa cells were treated with 15 μM MG-132 (Sigma-Aldrich) or 
DMSO for 7 h and then harvested for protein extraction.
Blue native-PAGE
Blue native SDS–PAGE was performed as previously reported (Rossi 
et al., 2010). A confluent layer of transfected HeLa cells and rat as-
trocytes was scraped and lysed into 7–10 volumes of BN buffer (1% 
Triton X-100, 12 mM NaCl, 500 mM 6-aminohexanoic acid, 20 mM 
Bis-Tris, pH 7.0; 2 mM EDTA; 10% glycerol), plus Protease Inhibitor 
Cocktail (Roche Diagnostic, Monza, Italy) on ice, vortexed every 10 
min for 1 h, and centrifuged at 22,000 × g for 30 min at 4°C. Super-
natants were collected and the total protein content calculated us-
ing the Bradford assay (Bio-Rad, Milan, Italy).
Twenty micrograms of protein sample was mixed with 5% CBB 
G-250 (Coomassie blue G-250) and loaded in polyacrylamide native 
gradient gels (4–9%). Twenty micrograms of ferritin was used as 
molecular weight standard (440 and 880 kDa). The running buffers 
were the anode buffer (25 mM imidazole, pH 7) and blue cathode 
buffer (50 mM tricine; 7.5 mM imidazole; 0.02% Coomassie blue 
G-250; pH 7). Electrophoresis was stopped when the tracking line of 
CCB G-250 dye had left the edge of the gel. Proteins were blotted 
onto polyvinylidene difluoride (PVDF) membranes (Millipore, Milan, 
Italy) for immunoblot analysis.
Plasmids, cell cultures, and transfection
Human AQP4 and AQP4-Δ4 CDS were cloned into the pTarget 
Mammalian Expression Vector system (Promega, Milan, Italy) and 
into pcDNA 6.2/C-EmGFP (Invitrogen). The Golgi-resident en-
zyme β-1,4-galactosyltransferase 1 (td-tomato-Golgi) and the ER 
chaperone protein calreticulin (FRP-ER) were also used for colo-
calization experiments.
Rat cortical astrocyte primary cultures were prepared as previ-
ously described (Nicchia et al., 2005).
HeLa, rat astrocyte, and TNC-1 (Mola et al., 2009) cell lines were 
maintained in Dulbecco’s high-glucose medium (Invitrogen) supple-
mented with 10% fetal bovine serum (Invitrogen) and penicillin/
streptomycin (Invitrogen). Six hours before transfection, the cells 
were plated at 60–70% of confluence using antibiotic-free medium. 
Cells were transfected with Optifect (Invitrogen) according to the 
manufacturer’s protocol and analyzed after 30–48 h.
Cycloheximide and MG-132 cell treatment
For CHX treatment, 48 h posttransfection, HeLa cells were treated 
with 30 μM CHX (Sigma-Aldrich, Milan, Italy) or dimethyl sulfoxide 
(DMSO) and harvested after various time points.
FIGURE 7: Analysis of the effect of AQP4-Δ4 on cell water transport. 
(A) A stable cell line expressing a high level of AQP4 was transiently 
transfected with AQP4-Δ4 (Δ4), and after 36 h water transport analysis 
was performed using the calcein-quenching method after osmotic 
shock at 10°C. Top, time course of the stable cell line; middle, time 
course of the cell line transiently transfected with the control vector 
(EV); bottom, time course of cell expressing AQP4-Δ4 (Δ4). (B) Mean 
values ± SEM of the time constant (n = 3–5 independent experiments; 
*p < 0.05). (C) kinetics of fluorescent calcein of wild-type and 
AQP4-Δ4 (Δ4) stable cell lines. (D) Mean values ± SEM of the time 
constant (n = 3–5 independent experiments).
FIGURE 8: Expression of AQP4-Δ4 in rat skeletal muscle. 
(A) Coamplification by RT-PCR of AQP4 splice variant with full-length 
AQP4 from rat EDL, quadriceps, FDB, and soleus muscles and 
cerebellum. Note the two bands visible in skeletal muscles. 
(B) Densitometric analysis of AQP4-Δ4 abundance in different muscles 
(*p < 0.05; n = 3). (C) Immunoblot analysis of AQP4 expression in the 
analyzed rat tissues.
Primer name Sequence
P1 GAGAGCTGCACTCTGGCTGG
P2 GTCTGCTTTCAGTGCGATCT
P3 ATCTTTGCCAGCTGTGATTC
P4 TGTTTGCTGGGCAGCTTTGC
P5 AAGGCGGTGGGGTAAGTGT
P6 CTGTGACTGCTTTCCAGAAAGC
P7 GGACATTTATTTGCAATATATTGGGTT
P8 TTCTTTAAAACGACGTTTGAATTCA
P9 ATTTTTGCCAGCTGTGATTC
P10 CGTCTGCTGTGCAGCTTTGC
TABLE 1: Primers used in this study.
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ImageJ and plotted against the time of treatment. Bands present in 
the chase samples were expressed as percentage of the signal pres-
ent in the pulse lane.
For proteasome inhibition experiments, 30 μM MG132 was 
added 3 h before the starvation period and included throughout the 
labeling and chase.
Immunofluorescence
Rat astrocytes and HeLa cells plated on coverslips were fixed in 4% 
paraformaldehyde, washed in PBS, and permeabilized with 0.3% 
Triton X-100 in PBS. After blocking with 0.1% gelatin in PBS, cells 
were incubated with primary antibodies for 1 h at room tempera-
ture. After washing in PBS, cells were incubated for 30 min with 
Alexa-conjugated secondary antibodies. Coverslips were mounted 
on slides with mounting medium and examined by using a Nikon 
Eclipse TE2000-E microscope equipped for epifluorescence and 
Plan Apo λ 10× objectives (Nikon, Milan, Italy). Digital images were 
obtained with a C4742-95 digital camera (Hamamatsu, Milan, Italy) 
and NIS-elements, version 3.30, software (Nikon). Once captured, 
the auto contrast function was applied to the whole images using 
Photoshop CS5 (Adobe, Italy).
Cells transfected with fluorescent protein expression vectors 
were fixed in 4% paraformaldehyde, washed in PBS, and examined 
by confocal microscopy (TCS SP3; Leica, Milan, Italy).
Antibodies
Anti-AQP4 was from Santa Cruz Biotechnology (goat polyclonal im-
munoglobulin G) and diluted to 1:400 for immunofluorescence and 
1:500 for immunoblot analysis. Rabbit anti-actin and anti-GFAP 
(Sigma) were used for immunoblots at 1:500. Anti-GFP for immuno-
precipitation was from Santa Cruz Biotechnology. The secondary 
antibodies used for Western blot included peroxidase-conjugated, 
donkey anti-goat and goat anti-rabbit (Santa Cruz Biotechnology) at 
a dilution of 1:7500. The secondary antibody used for immunofluo-
rescence was Alexa 594–conjugated donkey anti-goat (Molecular 
Probes, Milan, Italy) at a dilution of 1:1000.
Water transport measurements
Functional studies were performed on TNC1-AQP4, an astrocyte 
immortalized cell line stably transfected with AQP4 (Mola et al., 
2009). TNC1-AQP4 cells were transiently transfected with the plas-
mid encoding AQP4-Δ4 and TNC1-AQP4-Δ4 stably expressing 
cells. The 80–90% confluent cells grown on 20-mm-diameter round 
coverslips were incubated at 37°C for 45 min with 10 μM membrane 
permeable calcein-AM (Molecular Probes), which is trapped intrac-
ellularly after cleavage by esterases. As previously described (Mola 
et al., 2009), the calcein fluorescence signal was dependent on per-
fusate osmolarity (quenching method). The signal decreases upon 
perfusion with hypertonic solution as a consequence of water efflux 
and cell shrinkage. The fluorescence signal increases with a hypo-
tonic solution due to cell swelling.
After being rinsed in PBS (pH 7.4), the cover glasses were 
mounted in a custom perfusion chamber designed for rapid solu-
tion exchange without causing cell detachment. Solution exchange 
time was <200 ms at 40 ml/min perfusion rate. For osmotic water 
permeability measurements, solutions were exchanged between 
PBS and hypertonic saline (with added 150 mM d-mannitol). Solu-
tion osmolalities were measured using a freezing point–depression 
osmometer. Calcein fluorescence was measured continuously using 
an epifluorescence microscope (TE 2000S; Nikon Instruments) 
equipped with a charge-coupled device camera (MicroMax 512BFT; 
Princeton Instruments, Trenton, NJ) using a DeltaRAM high-speed 
multiwavelength illuminator (Photon Technology International, 
Protein sample preparation and Western blotting
Several 10-μm-thick cryosections of human and rat tissues were dis-
solved in seven volumes of RIPA lysis buffer (10 mM Tris-HCl, pH 7.4, 
140 mM NaCl, 1% Triton X-100, 1% Na deoxycholate, 0.1% SDS, 1× 
Protease Inhibitor Cocktail, 1 mM Na3VO4, 1 mM NaF, and 1 mM 
EDTA).
Transfected HeLa cells and rat astrocytes were washed once in 
ice-cold phosphate-buffered saline (PBS) and dissolved in RIPA buf-
fer as described.
Cells and tissues lysates were then sonicated for 10 s on ice, and 
after a 30-min incubation on ice, the samples were centrifuged at 
22,000 × g for 30 min at 4°C. Supernatants were collected, and 
protein concentration was determined using the Bradford assay 
(Bio-Rad).
Membrane proteins were dissolved in Laemmli Sample Buffer 
(Bio-Rad) and 50 mM dithiothreitol, heated to 37°C for 10 min, re-
solved on a 13% polyacrylamide gel, and transferred onto nitrocel-
lulose membranes (Immobilon PVDF; Millipore). After transfer, the 
membranes were blocked and incubated with antibodies. Reactive 
proteins were revealed with an enhanced chemiluminescent detec-
tion system (ECL-Plus; Pierce Euroclone, Milan, Italy) and visualized 
on a VersaDoc imaging system (Bio-Rad). Images were analyzed us-
ing ImageJ software (National Institutes of Health, Bethesda, MD). 
For relative quantification, the optical density value was determined 
for equal-sized boxes drawn around antibody-stained bands, with 
background values taken below each band of interest to account for 
nonspecific antibody staining in the lane.
Coimmunoprecipitation
Protein lysates prepared as described previously were incubated 
overnight at 4°C on a mechanical rotator with 2 μl of anti-GFP anti-
body (Santa Cruz Biotechnology, DBA, Milan, Italy). The next day, 
50 μl of prewashed agarose beads (rProteinG Agarose; Invitrogen) 
was added and incubated for 1 h at 4°C. Negative controls were set 
up by omitting the protein lysate or antibodies.
To precipitate the immunocomplexes, the samples were centri-
fuged at 22,000 × g at 4°C for 5 min and washed five times with 
washing buffer (0.2% Triton X-100; 10 mM Tris-HCl, pH 7.4; 150 mM 
NaCl, 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid [EGTA]) 
plus Protease Inhibitor Cocktail. Proteins were eluted from the aga-
rose beads by adding 50 μl of 2× Laemmli Sample Buffer and incu-
bating at 60°C for 10 min. The eluted proteins were subjected to 
SDS–PAGE as described.
Pulse chase
Twelve hours after transfection, HeLa cells were starved for 30 min in 
cysteine/methionine-free DMEM and then pulse labeled for 30 min 
with 400 μCi/ml [35S]methionine and [35S]cysteine (EasyTag EX-
PRESS35S protein labeling mix; Perkin Elmer, Milan, Italy) at 37°C.
After labeling, the cells were washed once with DMEM supple-
mented with 10% fetal bovine serum and 10-fold excess of cold methi-
onine and cysteine and then chased for 1–4 h in the same medium.
At different chase times (0–4 h), cells were lysed 30 min on ice in 
1% Triton X-100, 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM 
EDTA, and 1 mM EGTA plus Protease Inhibitor Cocktail. Lysates 
were centrifuged at 22,000 × g for 20 min, and supernatants were 
incubated overnight at 4°C on a mechanical rotator with 2 μl of anti-
AQP4 antibody (Santa Cruz Biotechnology).
Immunocomplexes were precipitated as described, and the 
eluted proteins were subjected to SDS–PAGE. Gels were dried and 
exposed to a phosphorimager screen, and the signal was visualized 
with the Storm PhosphorImager system (Molecular Dynamics, Milan, 
Italy). Densitometric analysis of protein bands was carried out using 
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